Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Total Liabilities (2016 - 2025)

National Research (NRC) has disclosed Total Liabilities for 16 consecutive years, with $120.9 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 19.39% to $120.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $120.9 million through Dec 2025, up 19.39% year-over-year, with the annual reading at $120.9 million for FY2025, 19.39% up from the prior year.
  • Total Liabilities hit $120.9 million in Q4 2025 for National Research, roughly flat from $121.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $121.4 million in Q3 2025 to a low of $55.9 million in Q2 2023.
  • Historically, Total Liabilities has averaged $82.0 million across 5 years, with a median of $73.6 million in 2021.
  • Biggest five-year swings in Total Liabilities: dropped 19.08% in 2022 and later skyrocketed 56.07% in 2024.
  • Year by year, Total Liabilities stood at $72.2 million in 2021, then dropped by 19.08% to $58.4 million in 2022, then increased by 25.77% to $73.5 million in 2023, then skyrocketed by 37.8% to $101.3 million in 2024, then grew by 19.39% to $120.9 million in 2025.
  • Business Quant data shows Total Liabilities for NRC at $120.9 million in Q4 2025, $121.4 million in Q3 2025, and $120.1 million in Q2 2025.